A wave of corporate earnings reports sent shares across the healthcare, staffing, and semiconductor sectors swinging sharply in midday trading on Wednesday, as investors weighed results that ranged from reassuring revenue beats to jarring guidance cuts. The session offered one of the more volatile midday pictures of the current earnings cycle, with several large-cap names moving by double-digit percentages. According to CNBC’s midday movers coverage, the moves reflected both company-specific developments and broader macro anxieties that have shadowed markets through the first half of 2026.

UnitedHealth and Abbott Pull Healthcare in Opposite Directions

UnitedHealth Group remained the most closely watched name of the session, with shares under sustained pressure following the company’s decision to withdraw its full-year earnings forecast. The managed care giant cited rising medical costs and unexpectedly high utilisation rates among Medicare Advantage members as the primary drivers of its revised outlook. The stock fell more than 8 percent in midday trading, extending a decline that has now erased a significant portion of gains built up over the prior twelve months. Analysts noted that the withdrawal of guidance, rather than a simple downward revision, signalled a degree of uncertainty that unsettled institutional holders.

Abbott Laboratories, by contrast, delivered a notably stronger performance after reporting second-quarter results that exceeded Wall Street expectations on both the top and bottom lines. The medical device and diagnostics company posted revenue growth driven in part by continued demand for its continuous glucose monitoring products, with its FreeStyle Libre platform showing particularly strong international uptake. Abbott shares climbed approximately 4 percent by midday, providing a partial offset to the broader pressure across the healthcare sector. The divergence between the two companies underscored how differently earnings season is treating payers versus device manufacturers within the same industry group. This pattern of widening intra-sector dispersion has become a recurring theme as investors grow more selective amid persistently elevated U.S. inflation pressures that continue to weigh on cost structures across the economy.

TSMC Provides Semiconductor Stability While Manpower Flags Labour Weakness

Taiwan Semiconductor Manufacturing Company offered one of the session’s more constructive data points, with its latest revenue figures reinforcing confidence in the durability of artificial intelligence-related chip demand. TSMC reported net revenue for the quarter that came in ahead of analyst estimates, supported by robust orders from leading fabless customers building out AI accelerator capacity. Shares of the Taiwanese chipmaker advanced roughly 3 percent in New York-listed trading, adding to a year-to-date gain that has made it one of the stronger performers among large-cap technology names. The results fed directly into optimism about the semiconductor supply chain at a time when questions about demand sustainability have lingered, a debate that has also surrounded other chipmakers as discussed in earlier coverage of Micron’s AI outlook.

Manpower Group told a markedly different story from the labour market’s demand side. The global workforce solutions company reported second-quarter earnings that missed consensus estimates and offered cautious forward guidance, pointing to softening hiring activity across several of its key European markets, particularly in France and Germany. The company’s revenue declined year over year as employers pulled back on temporary staffing contracts amid economic uncertainty. Shares fell sharply, dropping more than 9 percent by midday, making it one of the worst performers in the S&P 500 during the session. The results raised fresh questions about the health of the global labour market beyond the headline employment statistics that governments typically report.

Broader Market Context and What Earnings Season Signals

The midday moves took place against a backdrop of generally resilient index-level performance, with the major averages holding modest gains even as individual names registered outsized swings. The S&P 500 and Nasdaq Composite both traded in positive territory, supported partly by strength in technology and energy. However, the breadth of the rally remained uneven, with healthcare acting as a drag. Market strategists noted that the current earnings season is functioning as a stress test for valuations that had stretched ahead of the reporting cycle, with companies that miss on guidance being punished more severely than those that beat on current-period results are rewarded.

The pattern of sector-level divergence visible on Wednesday reflects a market environment in which investors are scrutinising forward-looking statements with unusual intensity. With the Federal Reserve’s next policy meeting approaching and inflation data still elevated relative to target, corporate outlooks have taken on added significance as proxies for economic momentum. The results from UnitedHealth in particular will likely prompt renewed scrutiny of managed care earnings across the sector, while TSMC’s figures are expected to inform sentiment heading into reports from other chipmakers and their downstream customers in the coming days. Whether Wednesday’s mixed midday picture consolidates or reverses into the close will depend heavily on whether any additional earnings surprises emerge before the bell.